Skip to main content

Aurora Analytica

Aurora Analytica provides the Aurora Suite™, an operating system for clinical development that integrates seven decision engines covering trial feasibility, site identification, country strategy, and enrollment simulation. The platform replaces manual spreadsheet workflows with auditable, traceable intelligence, with its EKO™ ranking algorithm scoring countries against 10-15 weighted drivers. A global CRO measured a 53% reduction in end-to-end country-ranking time after adopting the platform.

Traction 8/10
Oslo, Norway · HQ
Founded 202441K+ followers
  • Data & Analytics
  • Healthcare Technology
  • Software Only
  • Artificial Intelligence
  • Biotechnology
  • Drug Discovery & Therapeutics
  • Enterprise Software
Updated 8 days ago

Funding

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Clinical development teams face fragmented data sources, manual spreadsheet-based workflows, and compressed timelines when making critical decisions about trial feasibility, country selection, and enrollment strategy. These inefficiencies lead to slow, poorly documented decisions that are difficult to defend to sponsors or regulatory bodies, increasing the risk of costly trial delays and failures.

Solution

Aurora Analytica provides the Aurora Suite™, an all-in-one operating system for clinical development that integrates seven core decision engines with an orchestration and enablement layer. The platform covers trial feasibility, site identification, country strategy, and enrollment simulation, allowing teams to work from a single, unified system. Each module is built on a deterministic, rule-based foundation designed by clinical domain experts, with AI applied only where it genuinely improves speed and capability. Every output is auditable and traceable back to its inputs, replacing gut calls with defensible, study-specific intelligence that teams can present to sponsors or internal boards. The suite is modular, so organizations can start with one module and expand as needs grow, with all modules working together for stronger results.

Target Audience

Primary customers are clinical development and feasibility teams at pharmaceutical companies, biotech firms, and contract research organizations (CROs) who need to design, de-risk, and defend trial strategy across their portfolios.

Features

  • Seven core decision engines including Trial Core™ (550K+ trial records across 7+ integrated directories), Plume™ (dynamic intelligence database), Patient Xplore™, Site Net™, Simulator-L™, Geo Matrix™, and Simulator-C™
  • EKO™ ranking algorithm that scores countries against 10-15 weighted drivers, up from roughly 6 in manual workflows
  • ACE data integration that combines user files into a single dataset via drag-and-drop, eliminating manual data entry
  • Aurora Intel™ organizational backbone providing secure, versioned project workspaces with audit trails and document intelligence
  • Starlite-Flow™ workflow automation and Aurora Admin™ user management for enterprise-grade governance
  • Structured, auditable calculation layer where every number traces back to its input, enabling verification and QC
  • Presentation-ready visual outputs in the customer's own brand colors for direct use in client deliverables
This profile is AI-generated and may contain inaccuracies.